Two Sigma Securities’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1K Buy
+13,816
New +$18.9K ﹤0.01% 1492
2026
Q1
Sell
-17,211
Closed -$19.4K 2011
2025
Q4
$19.4K Buy
+17,211
New +$24.2K ﹤0.01% 1186
2023
Q3
Sell
-24,131
Closed -$27.8K 3300
2023
Q2
$27.8K Buy
+24,131
New +$29.2K ﹤0.01% 2467
2023
Q1
Sell
-13,410
Closed -$14.9K 3066
2022
Q4
$14.9K Sell
13,410
-836
-6% -$1.3K ﹤0.01% 2309
2022
Q3
$25K Buy
+14,246
New +$31.1K ﹤0.01% 2273
2018
Q4
Sell
-698
Closed -$5K 2605
2018
Q3
$5K Buy
+698
New +$5.38K ﹤0.01% 2513
2017
Q1
Sell
-748
Closed -$16K 1045
2016
Q4
$16K Buy
+748
New +$19.9K 0.01% 664

Other funds holding NNVC

Two Sigma Securities's NNVC Position: Q2 2026 in Review

Two Sigma Securities opened a new position in NanoViricides (NNVC) in Q2 2026: 13,816 shares worth $19.1K. The stake represents ﹤0.01% of the portfolio and ranks #1492 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in NNVC as recently as Q4 2025.

Two Sigma Securities first reported a position in NNVC in Q4 2016 and has held it in 7 quarters since. The position peaked at $27.8K in Q2 2023. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Two Sigma Securities held 13,816 shares of NanoViricides worth $19.1K as of Q2 2026.
  • NanoViricides was a new Two Sigma Securities position in Q2 2026.
  • NanoViricides made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1492 holding.
  • Two Sigma Securities first reported a position in NanoViricides in Q4 2016 and has held it in 7 quarters since.
  • Two Sigma Securities's NanoViricides position peaked at $27.8K in Q2 2023.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.